Skip to main content

Table 4 Mean and standard deviation of serum total oxidative and anti-oxidative capacity in patients participated in two groups taking high and low doses of vitamin Dat the beginning and end of the study

From: The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status

Variables

Time of the study

 

Beginning of study

End of study

P-valuec

aP-value

bP-value

Serum TOS (ng/mL)

   

0.023

0.514

 Low dose group

2.94 ± 1.05

3.03 ± 0.80

0.70

  

 High dose group

3.37 ± 0.96

2.99 ± 1.00

0.17

  

 P-value d

0.15

0.90

   

Serum TAC (pg/mL)

   

0.209

0.599

 Low dose group

0.57 ± 0.11

0.56 ± 0.12

0.47

  

 High dose group

0.57 ± 0.13

0.56 ± 0.09

0.30

  

 P-valued

0.93

0.86

   
  1. The values are reported as mean ± standard deviation
  2. aP –value for complementary efficacy (changes comparison) by Student T-test
  3. bP-value for complementary efficacy (changes comparison) after adjustment by ANCOVA test for BMI, and baseline values
  4. cP –value for within group comparison using paired t test
  5. dP –value for between groups comparison using Student T-test